WHY IS YOUR RESEARCH IMPORTANT AND HOW WILL IT INFLUENCE THE UNDERSTANDING AND TREATMENT OF MS?
Current therapeutics in MS are good at targeting the inflammatory nature of the disease to limit the immune attacks on central nervous system (CNS) myelin. Despite their effectiveness in blunting the relapse rate in MS patients, they are limited in stopping disease progression. Research looking at therapeutics that help repair the damage from the immune attacks and removal of debris is crucial to treating MS. This can potentially improve the quality of life and limit disability in patients, particularly those with progressive MS where the damage is prominent. Furthermore, it could contribute to a better understanding of the mechanisms that are in play during MS progression.